Silo Pharma (SILO) Stock Price, News & Analysis

Company Overview

Silo Pharma. Inc., a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief. The company's preclinical products include SPC-14 to treat Alzheimer's disease; and SPU-16, a central nervous system homing peptide targeting the central nervous system with indication in multiple sclerosis. It also seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin and ketamine, as well as depression, mental health issues, and neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Key Stats

• Today's Range: $1.03 to $1.07
• 50-Day Range: $1.01 to $3.47
• 52-Week Range: $0.84 to $4.50
• Volume: 48,893 shs
• Average Volume: 1.93 million shs
• Market Capitalization: $4.75 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Silo Pharma Stock Analysis - MarketRank™

Silo Pharma scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Silo Pharma.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Silo Pharma has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.12% of the float of Silo Pharma has been sold short.

Short Interest Ratio / Days to Cover

Silo Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Silo Pharma has recently decreased by 25.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Silo Pharma does not currently pay a dividend.

Dividend Growth

Silo Pharma does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.12% of the float of Silo Pharma has been sold short.

Short Interest Ratio / Days to Cover

Silo Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Silo Pharma has recently decreased by 25.38%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

Silo Pharma has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

Search Interest

Only 2 people have searched for SILO on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Silo Pharma insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 5.56% of the stock of Silo Pharma is held by insiders.

Percentage Held by Institutions

Only 5.58% of the stock of Silo Pharma is held by institutions.

SILO Stock Analysis - Frequently Asked Questions

How have SILO shares performed this year?

Silo Pharma's stock was trading at $1.44 at the start of the year. Since then, SILO shares have decreased by 26.4% and is now trading at $1.06.
View the best growth stocks for 2024 here.

How were Silo Pharma's earnings last quarter?

Silo Pharma, Inc. (NASDAQ:SILO) released its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.31) earnings per share (EPS) for the quarter. The company earned $0.02 million during the quarter. Silo Pharma had a negative net margin of 4,881.57% and a negative trailing twelve-month return on equity of 55.30%.

How do I buy shares of Silo Pharma?

Shares of SILO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/13/2024
• Today: 9/19/2024
• Next Earnings (Estimated): 11/11/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Apparel, finished products from fabrics & similar materials
• Sub-Industry: Apparel
• Current Symbol: NASDAQ:SILO
• CUSIP: N/A
• CIK: 1514183
• Web: silopharma.com
• Phone: (718) 400-9031
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-3,700,000.00
• Net Margins: -4,881.57%
• Pretax Margin: -4,784.38%
• Return on Equity: -55.30%
• Return on Assets: -43.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.84
• Quick Ratio: 5.84

Sales & Book Value

• Annual Sales: $72,102.00
• Price / Sales: 41.18
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.14 per share
• Price / Book: 0.50

Miscellaneous

• Outstanding Shares: 2,803,000
• Free Float: 2,647,000
• Market Cap: $2.97 million
• Optionable: Not Optionable
• Beta: -0.24